Rein Piir
Director/Board Member at IRLAB THERAPEUTICS AB
Net worth: 43 519 $ as of 2024-04-29
Network origin in Rein Piir first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
33
| Public Company | Pharmaceuticals: Major | 33 |
| Public Company | Pharmaceuticals: Major | 24 | |
| Public Company | Pharmaceuticals: Major | 21 | |
| Public Company | Pharmaceuticals: Major | 7 | |
| Public Company | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Rein Piir via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Corporate Officer/Principal Masters Business Admin Graduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree | |
| University of Stockholm | College/University | Corporate Officer/Principal Masters Business Admin Director/Board Member Masters Business Admin Undergraduate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| University of Gothenburg | College/University | Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Chief Executive Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact Investor Relations Contact Corporate Officer/Principal General Counsel General Counsel | |
| University of Lund | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal | |
| Carlsson Research AB | Founder Founder Founder Director of Finance/CFO Chief Tech/Sci/R&D Officer | ||
| BIOINVENT INTERNATIONAL AB | Biotechnology | Investor Relations Contact Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Royal Institute of Technology | College/University | Anna Yvonne Monica Malm Bernsten | Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer | |
BioPhausia AB
 BioPhausia AB Medical DistributorsDistribution Services BioPhausia AB operates as a pharmaceutical company. It markets and distributes original drugs, generic products, and the parallel-imported medicines. The company is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer Director/Board Member Chairman | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Oncopeptides Incentive AB | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | ||
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
| Handelshögskolan i Göteborg | College/University | Masters Business Admin Graduate Degree Graduate Degree | |
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| OREXO AB | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer General Counsel | |
| Pfizer AB | Corporate Officer/Principal Chief Executive Officer Public Communications Contact | ||
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman | |
| OxyPharma AB | Director/Board Member Director/Board Member Chairman | ||
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Chairman Director/Board Member Director/Board Member | |
| GETINGE AB | Medical Specialties | Director/Board Member Director/Board Member Director of Finance/CFO | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Svenskt Näringsliv
 Svenskt Näringsliv Miscellaneous Commercial ServicesCommercial Services Svenskt Näringsliv provides consulting services. It focuses on protection, support, and promotion of the interests of businesses. The firm provides its members with knowledge in a number of areas including labor market and law, taxes, corporate law and intellectual property, economics and macro analysis, constitutional and legal protection, security and risk management, and trade policy. The company was founded on March 29, 2001 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
| Astra Hässle AB | Chief Executive Officer Chief Executive Officer | ||
| LEO Pharma AB | Director/Board Member Corporate Officer/Principal | ||
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chief Operating Officer Chairman | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Doctorate Degree Graduate Degree | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chairman Director/Board Member | |
| Chalmers University of Technology | College/University | Corporate Officer/Principal Chairman | |
Cross Pharma AB
 Cross Pharma AB Medical DistributorsDistribution Services Part of Unimedic AB, Cross Pharma AB is a supplier of medical equipment. The company is based in Stockholm, Sweden. The Swedish company was founded by Karl Johan Kristian Perlhagen. Cross Pharma was acquired by Unimedic AB from Medivir AB on June 30, 2013 for $2.91 million. | Medical Distributors | Director/Board Member Chief Executive Officer | |
Gesynta Pharma AB
 Gesynta Pharma AB Pharmaceuticals: MajorHealth Technology Gesynta Pharma AB develops and manufactures novel oral treatments for patients with chronic inflammatory conditions. The company was founded by Gunilla Anders Ekström, Charlotte Elisabet Edenius, Urban Paulsson, Ralf Morgenstern, Per-Johan Göte Jakobsson and Patric Stenberg in 2017 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
| SPECTRACURE AB | Electronic Equipment/Instruments | Chairman Chairman | |
Gyros AB
 Gyros AB Medical SpecialtiesHealth Technology Gyros AB engages in the utilization of microfluidic technologies to miniaturize and automate immunoassays. Its Gyrolab xP miniaturizes, integrates, and automates analysis of samples in parallel. The firm's technology delivers immunoassay data through automated control of centrifugal and capillary forces to steer liquid flow in proprietary nanoliter-scale microfluidic structures.The company offers Gyrolab microlaboratory, in the form of a compact disk, can process samples at nanoliter scale, controlled by Gyrolab Workstation. Gyros was founded in 2000 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Beactica Therapeutics AB
 Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Medical Distributors | Director/Board Member Chief Executive Officer | |
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
| MOBERG PHARMA AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin |
Statistics
International
| Sweden | 45 |
| United States | 4 |
| United Kingdom | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 20 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Distribution Services | 4 |
| Finance | 2 |
Operational
| Director/Board Member | 464 |
| Corporate Officer/Principal | 160 |
| Chairman | 160 |
| Independent Dir/Board Member | 104 |
| Chief Executive Officer | 90 |
Most connected contacts
- Stock Market
- Insiders
- Rein Piir
- Company connections
